Hospira Gemcitabine Injection 38 mg/mL, 200 mg/5.3 mL vial

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Nusipirk tai dabar

Veiklioji medžiaga:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Prieinama:

Hospira Australia Pty Ltd

INN (Tarptautinis Pavadinimas):

Gemcitabine hydrochloride

Vaisto forma:

Injection, concentrated

Sudėtis:

Excipient Ingredients: water for injections; hydrochloric acid; sodium hydroxide

Vartojimo būdas:

Intravenous

Vienetai pakuotėje:

1 x 5.3 mL pack

Klasė:

Medicine Listed (Export Only)

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

Gemcitabine is indicated for treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelian ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first line therapy. Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.

Produkto santrauka:

Visual Identification: A clear, colourless or light straw-coloured solution, practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Listed (Export Only)

Leidimo data:

2011-04-20